Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytek Biosciences (CTKB) Change in Accured Expenses (2020 - 2025)

Historic Change in Accured Expenses for Cytek Biosciences (CTKB) over the last 6 years, with Q3 2025 value amounting to -$1.4 million.

  • Cytek Biosciences' Change in Accured Expenses fell 12500.89% to -$1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year increase of 16047.85%. This contributed to the annual value of -$817000.0 for FY2024, which is 21207.13% down from last year.
  • Latest data reveals that Cytek Biosciences reported Change in Accured Expenses of -$1.4 million as of Q3 2025, which was down 12500.89% from $2.8 million recorded in Q2 2025.
  • In the past 5 years, Cytek Biosciences' Change in Accured Expenses ranged from a high of $8.9 million in Q4 2021 and a low of -$4.8 million during Q2 2024
  • For the 5-year period, Cytek Biosciences' Change in Accured Expenses averaged around $927421.1, with its median value being $370000.0 (2021).
  • Data for Cytek Biosciences' Change in Accured Expenses shows a peak YoY increase of 236890.76% (in 2024) and a maximum YoY decrease of 36086.22% (in 2024) over the last 5 years.
  • Over the past 5 years, Cytek Biosciences' Change in Accured Expenses (Quarter) stood at $8.9 million in 2021, then plummeted by 47.72% to $4.6 million in 2022, then crashed by 97.44% to $119000.0 in 2023, then skyrocketed by 2368.91% to $2.9 million in 2024, then plummeted by 147.96% to -$1.4 million in 2025.
  • Its last three reported values are -$1.4 million in Q3 2025, $2.8 million for Q2 2025, and -$2.1 million during Q1 2025.